» Articles » PMID: 21031587

Intractable Vomiting As the Initial Presentation of Neuromyelitis Optica

Overview
Journal Ann Neurol
Specialty Neurology
Date 2010 Oct 30
PMID 21031587
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

We report 12 aquaporin-4 antibody-positive patients (12% of seropositive Mayo Clinic patients identified since 2005) whose initial presenting symptom of neuromyelitis optica was intractable vomiting. The initial evaluation in 75% was gastroenterologic. Vomiting lasted a median of 4 weeks (range, 2 days-80 weeks). Optic neuritis or transverse myelitis developed after vomiting onset in 11 patients (median interval, 11 weeks; range, 1-156). At last evaluation (median, 48 months after vomiting onset), 7 patients fulfilled neuromyelitis optica diagnostic criteria. Our clinical, pathologic and neuroimaging observations suggest the aquaporin-4-rich area postrema may be a first point of attack in neuromyelitis optica.

Citing Articles

Neuromyelitis Optica: A Peek Into the Brain Through the Eyes.

Aher P, Bhavsar D, Toshniwal S, Bora R, Jagadish R Cureus. 2024; 16(8):e67408.

PMID: 39310466 PMC: 11414768. DOI: 10.7759/cureus.67408.


NMOSD and MOGAD: an evolving disease spectrum.

Uzawa A, Oertel F, Mori M, Paul F, Kuwabara S Nat Rev Neurol. 2024; 20(10):602-619.

PMID: 39271964 DOI: 10.1038/s41582-024-01014-1.


Neuromyelitis optica spectrum disorder: Exploring the diverse clinical manifestations and the need for further exploration.

Noori H, Marsool M, Gohil K, Idrees M, Subash T, Alazzeh Z Brain Behav. 2024; 14(8):e3644.

PMID: 39135307 PMC: 11319236. DOI: 10.1002/brb3.3644.


Characteristics of recurrence in area postrema-onset NMO spectrum disorder - a retrospective cohort study.

Zhang X, Wu J, Lin J, Lin S, Lin A BMC Neurol. 2024; 24(1):165.

PMID: 38773402 PMC: 11107041. DOI: 10.1186/s12883-024-03667-3.


Patterns of Adult Neuromyelitis Optica Spectrum Disorder Patients Compared to Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Alqwaifly M, Althobaiti A, AlAibani N, Banjar R, Alayed R, Alsubaie S Cureus. 2023; 15(10):e47565.

PMID: 38021935 PMC: 10666196. DOI: 10.7759/cureus.47565.